---
title: "Policy Pulse — Global Spillover — 22 Jul 2026"
ticker: "XOM:CVX:OXY:HAL:SLB:DAL:UAL:AAL:CCL:RCL:LMT:NOC:GD:RTX:TEVA:MYL:LLY:MRK:JNJ:ABBV:MSFT:NVDA:GOOGL:AMZN:PLTR:ORCL:ONGC:OIL:IOC:BPCL:HPCL:MRPL"
date: "2026-07-22"
tags: ["policy-pulse","global","hormuz","oil","pharma","defence","ai","genesis-mission","jordan-trade"]
summary: "US-Iran war enters 11th night of strikes; Trump threatens Iranian infrastructure. Hormuz closed — oil 5+, ONGC/OCD gain, refiners bleed. Trump generic drug tariff timeline hits TEVA, MYL globally. US-Jordan trade deal signed. Genesis B AI-for-science unveiled."
model: "deepseek-chat"
---

## 🌍 Global Spillover Watch — July 22, 2026

### 1. 🇮🇷 US-Iran War — 11th Consecutive Night of Strikes; Hormuz Remains Closed

The US launched its 11th straight night of CENTCOM strikes on Iranian targets. Trump threatened to bomb Iranian bridges and power plants (including in Tehran) each time Iran fires at ships in the Strait of Hormuz. Iran countered by threatening to strike US-linked infrastructure across the Middle East. Diplomatic efforts by Oman and ASEAN remain stalled. Rubio accused Iran of not being "serious" about negotiations.

**Oil markets:** Brent $94.33 (+3.7%), WTI $87.28 (+3.5%). Gold at two-week high $4,140. Silver near $60.

**Indian impact:** IOC and MRPL halted Iraq crude loadings. Rupee fell to 96.56/USD. Nifty lost 191 pts.

**Stock signals (US):**
| Stock | Impact | Reason |
|-------|--------|--------|
| XOM | 🟢 BUY | $95+ Brent = record upstream margins; largest integrated supermajor |
| CVX | 🟢 BUY | Strong Permian production; 45%+ of production is oil-linked |
| OXY | 🟢 BUY | Most leveraged to WTI among majors; every $1 of WTI = substantial FCF delta |
| HAL | 🟢 BUY | OFS demand rising; international revenue growing |
| SLB | 🟢 BUY | Global OFS leader; Middle East and deepwater activity rising |
| DAL | 🔴 SELL | ATL-JNB, JFK-TLV among routes affected; fuel costs crushing margins |
| UAL | 🔴 SELL | International-heavy network; $95 jet fuel unprofitable for long-haul |
| LMT | 🟢 BUY | Direct warship, missile, and F-35 sustainment demand from active conflict |
| NOC | 🟢 BUY | B-21, missile systems, electronic warfare all in high demand |
| GD | 🟢 BUY | Shipbuilding (Hormuz blockade = naval vessel demand) + land systems |
| RTX | 🟢 BUY | Missiles, missile defense, and ISR systems for prolonged conflict |

**Stock signals (India):**
| Stock | Impact | Reason |
|-------|--------|--------|
| ONGC | 🟢 BUY | Domestic crude producer directly benefits from $95+ Brent |
| OIL | 🟢 BUY | Similarly benefits from higher crude realizations |
| IOC | 🔴 SELL | Refiner hit by crude cost + supply disruption from Iraq halt |
| BPCL | 🔴 SELL | Same crude cost pressure + under-recovery risk |
| HPCL | 🔴 SELL | Most exposed to under-recoveries; government may not fully pass through |
| MRPL | 🔴 SELL | Stopped Iraq loadings; margin pressure from higher feedstock costs |

### 2. 🔴 Trump Generic Drug Tariff — Global Pharma Implications

Trump's generic drug tariff timeline (0% for 2 years → 100% → 200%) is a global story:

**Impact on non-Indian generic players:**
| Stock | Impact | Reason |
|-------|--------|--------|
| TEVA | 🔴 SELL | Israel-based but huge US generics book; 200% tariff = existential for many ANDAs |
| MYL | 🔴 SELL | Pure generics; 200% tariff makes US generic business unviable |
| NOVN (Novartis Sandoz) | 🔴 SELL | Sandoz generics exposed; but parent diversified |
| LLY | 🟢 BUY | Branded-only; Mounjaro/Zepbound not impacted; tariff moat against generic competition |
| MRK | 🟢 BUY | Keytruda + vaccine portfolio; zero generic tariff risk |
| ABBV | 🟢 BUY | Skyrizi/Rinvoq branded; Humira biosimilar competition already priced in |

### 3. 🇺🇸 US-Jordan Trade Deal

US and Jordan signed reciprocal trade agreement on Jul 21. US tariffs on Jordanian goods reduced to 10%. Jordan keeps duty-free access for US exports. Apparel/garment sector gets preferential access.

**Stock impact:** No material US stock implications — Jordan is a $3.5B trade partner. Geopolitically positive (strengthens Middle East ally during Hormuz crisis).

### 4. 🤖 US Genesis AI Mission — $5B+ Federal AI-for-Science

The Trump administration announced $5B+ in federal commitments for the Genesis Mission (AI for scientific discovery). Targeted areas: healthcare (root causes of chronic disease), semiconductors, quantum computing, energy, national security. 15+ agencies involved.

| Stock | Impact | Reason |
|-------|--------|--------|
| MSFT | 🟢 BUY | Azure + AI platform likely infrastructure backbone; existing DOE contracts |
| NVDA | 🟢 BUY | GPU compute critical for DOE national labs and AI-for-science compute demands |
| GOOGL | 🟢 BUY | DeepMind + Google Cloud positioned for healthcare and science AI applications |
| AMZN | 🟢 BUY | AWS government cloud services + AI platform |
| PLTR | 🟢 BUY | AIP platform used by US government for data integration across agencies |
| ORCL | 🟢 BUY | Oracle government cloud growing; data management for federal science datasets |

---

## 📋 Cross-Border Stock Signals Summary

| Region/Theme | Direction | Key Tickers | Narrative |
|--------------|-----------|-------------|-----------|
| Crude Oil (Hormuz) | 🟢 BUY US | XOM, CVX, OXY, HAL, SLB | $95+ Brent = supermajor windfall |
| Defence (Hormuz) | 🟢 BUY US | LMT, NOC, GD, RTX | Active conflict drives sustained procurement |
| Airlines (Fuel) | 🔴 SELL US | DAL, UAL, AAL | Jet fuel crushing margins at $95 Brent |
| Oil (India) | 🟢 BUY IN | ONGC, OIL | Domestic producers benefit from high crude |
| Refiners (India) | 🔴 SELL IN | IOC, BPCL, HPCL, MRPL | Crude cost + supply disruption |
| Pharma Generic | 🔴 SELL | TEVA, MYL, SUNPHARMA, LUPIN | 200% tariff by 2029 is structural threat |
| Pharma Branded | 🟢 BUY | LLY, MRK, JNJ, ABBV | Protected by patent moat; generic tariff irrelevant |
| AI / Tech (Global) | 🟢 BUY US | MSFT, NVDA, GOOGL, AMZN, PLTR | $5B Genesis AI + sustained govt AI demand |